Literature DB >> 9477008

Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

E G Jönsson1, D Goldman, G Spurlock, J P Gustavsson, D A Nielsen, M Linnoila, M J Owen, G C Sedvall.   

Abstract

Concentrations of monoamine metabolites (MM) in lumbar cerebrospinal fluid (CSF) have been used extensively as indirect estimates of monoamine turnover in the brain. We investigated possible relationships between DNA polymorphisms in the tryptophan hydroxylase (TPH) and catechol-O-methyltransferase (COMT) genes and CSF concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in healthy volunteers (n = 66). Lower CSF 5-HIAA levels were found in men with the TPH U allele (p = 0.005), but not in women. A similar but less significant pattern was observed for CSF HVA. No relationship was found between the TPH polymorphism and CSF MHPG. COMT genotypes did not relate significantly to MM concentrations. The results suggest that TPH genotypes participate differentially in the regulation of serotonin turnover rate under presumed steady state in the central nervous system of men. Due to the uncertain functional relevance of the DNA polymorphism investigated and the many calculations performed, the results should be interpreted with caution until replicated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9477008     DOI: 10.1007/bf02922258

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

Review 1.  Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Authors:  H C Guldberg; C A Marsden
Journal:  Pharmacol Rev       Date:  1975-06       Impact factor: 25.468

2.  Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism.

Authors:  D A Nielsen; M Dean; D Goldman
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

3.  The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin.

Authors:  J R COOPER; I MELCER
Journal:  J Pharmacol Exp Ther       Date:  1961-06       Impact factor: 4.030

4.  Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2.

Authors:  M H Grossman; B S Emanuel; M L Budarf
Journal:  Genomics       Date:  1992-04       Impact factor: 5.736

5.  Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.

Authors:  G Oxenstierna; G Edman; L Iselius; L Oreland; S B Ross; G Sedvall
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

6.  Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.

Authors:  G Sedvall; B Fyrö; B Gullberg; H Nybäck; F A Wiesel; B Wode-Helgodt
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

7.  Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

Authors:  B Sandgárde; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

8.  Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.

Authors:  M Pecins-Thompson; N A Brown; S G Kohama; C L Bethea
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

9.  Binding of progesterone to nerve cell membranes of rat brain using progesterone conjugated to 125I-bovine serum albumin as a ligand.

Authors:  F C Ke; V D Ramirez
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

10.  No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity.

Authors:  J K Daniels; N M Williams; J Williams; L A Jones; A G Cardno; K C Murphy; G Spurlock; B Riley; P Scambler; P Asherson; P McGuffin; M J Owen
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

View more
  23 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 2.  [The value of pharmacogenetic tests in antidepressive medication therapy].

Authors:  J Kirchheiner; J Sasse; I Roots; J Brockmöller; M Bauer
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

Review 3.  Stress, genes and the biology of suicidal behavior.

Authors:  Dianne Currier; J John Mann
Journal:  Psychiatr Clin North Am       Date:  2008-06

Review 4.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.

Authors:  S Anttila; K Huuhka; M Huuhka; R Rontu; K M Mattila; E Leinonen; T Lehtimäki
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

Review 6.  Behavioral and pharmacogenetics of aggressive behavior.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2012

7.  Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes.

Authors:  Michelle A Patriquin; Sara C Hamon; Mark J Harding; Ellen M Nielsen; Thomas F Newton; Richard De La Garza; David A Nielsen
Journal:  Psychiatr Genet       Date:  2017-10       Impact factor: 2.458

Review 8.  Genes associated with addiction: alcoholism, opiate, and cocaine addiction.

Authors:  Mary Jeanne Kreek; David A Nielsen; K Steven LaForge
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 9.  From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.

Authors:  Alessandro Serretti; Paola Artioli
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

10.  An Association Study of the A218C Polymorphism of the Tryptophan Hydroxylase 1 Gene with Eating Disorders in a Korean Population: A Pilot Study.

Authors:  Youl-Ri Kim; Jong-Min Woo; Si Young Heo; Jeong Hyun Kim; Soo-Jin Lim; Bum-Hee Yu
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.